patent

Honda: 2&4 track car concept

Honda is maybe serious with its new wonderful Project 2&4 concept. This was a roadster that was originally presented at the 2015 Frankfurt auto show. Honda designers made a concept car that tried to fill the gap between the world of motorcycles and high-performance sports cars. Therefore they derived the name 2&4 car concept. It seems that [...]

By |2017-09-08T12:46:45+05:30March 4th, 2017|Patent|0 Comments

Touch ID in iPhone – live in a different form

Touch ID is Apple's iPhone and iPad biometric fingerprint recognition system, used to verify Apple Pay payments and to supplement device passcodes and in-app passwords. This has First introduced in 2013, Touch ID is built into the Home button of the iPhone 5s and later, and ipad Touch ID is built around a capacitive [...]

By |2017-09-08T12:47:20+05:30March 4th, 2017|Patent|0 Comments

Claim Construction: “Support an entire body”

SCAG and TORO are competitors in the lawnmower market.  In 2016, SCAG sued TORO for infringing its U.S. Patent No. 8,186,475 that covers a vehicle (lawnmower) having an operator-platform-suspension-system. This design differs from the more traditional seat-suspension because it supports the “entire body” of the operator and helps reduce harmful shock and vibrations on users. Metalcraft [...]

By |2017-09-08T12:50:22+05:30March 3rd, 2017|Patent|0 Comments

Win-Win for All: FDA Approves Olmesartan Generic

In the  1st week of November FDA approved generic versions of Olmesartan and its combinations with amlodipine and/or hydrochlorothiazide. The development would have been quite contempt but for the 180-day exclusivity granted to Mylan for its generic equivalents of Benicar® and Benicar® HCT drug products. As readers with even very little attachment to lawsuits [...]

By |2017-09-08T13:15:25+05:30December 28th, 2016|Patent, USA|0 Comments

FDA Approves Olmesartan Generics

As readers with even very little attachment to lawsuits on intersection of patent and FDA law would know that this drug product had been a subject of herculean tug o’ war between generic rivals- Mylan (Mylan N.V. is an American global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices [...]

By |2017-09-08T13:39:14+05:30December 23rd, 2016|Patent|0 Comments
Go to Top